HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β
Open Access
- 12 March 2019
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 10 (21) , 2068-2085
Abstract
HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1Keywords
This publication has 77 references indexed in Scilit:
- Acidic extracellular microenvironment and cancerCancer Cell International, 2013
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsNature, 2012
- Oncostatin M Promotes Mammary Tumor Metastasis to Bone and Osteolytic Bone DegradationGenes & Cancer, 2012
- Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell linesBMC Cancer, 2011
- gp130 at the nexus of inflammation, autoimmunity, and cancerJournal of Leukocyte Biology, 2010
- NF-κB/STAT3/PI3K signaling crosstalk in iMycEμ B lymphomaMolecular Cancer, 2010
- Why not treat human cancer with interleukin-1 blockade?Cancer and Metastasis Reviews, 2010
- Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancerCytokine & Growth Factor Reviews, 2010
- Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cellsOncogene, 2009
- Identification of proteins within the nuclear factor-κ B transcriptional complex including estrogen receptor-αAmerican Journal of Obstetrics and Gynecology, 2007